ClinicalTrials.gg
RecruitingNCT07329075Updated Jan 9, 2026

Soft Robot for Rehabilitation of Hand Function After Stroke

An interventional study of new soft robotic glove in Stroke, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-09.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 54 studies in Stroke by Chinese University of Hong Kong — 20 open to participants now, 21 under way, none of them phase 3. Stroke · Chinese University of Hong Kong.

Planned enrollment
22nd of 41
60 · median 64
Started
2026
with 1 other
No phase
38 of 54
15 open now
Primary completion
2028-12
later than 15 of 20 live
Registered
51st of 54
by date

Among the 54 studies in Stroke by Chinese University of Hong Kong, this one is the 22nd largest by planned enrollment of the 41 interventional ones that give a count, is one of 2 that started in 2026, is one of 38 with no phase, reaches primary completion later than 15 of the 20 other live ones, and was the 51st registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

20 of the 54 studies in Stroke by Chinese University of Hong Kong are open now, in 4 countries. Recruiting first, the newest first:

14 more — sign in →

By country, each count listing its studies:

All 20 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Stroke by Chinese University of Hong Kong, or all of them as a file.
02

Study summary

The goal of this clinical trial is to investigate the feasibility of using the Soft Forearm Robot system for wrist and forearm recovery of hemiplegic subjects suffered from stroke.

Participant will attend 20 training sessions and 3 assessment sessions. This system will leverage electromyography (EMG) signals for intention detection and regulating the movement and the contact for different tasks and objects, ensuring adaptive and precise control for rehabilitation tasks. A systematic clinical study involving sixty stroke patients divided into three groups will evaluate the effectiveness of our innovative design compared to conventional rehabilitation methods. By conducting a randomized controlled trial (RCT), we aim to provide robust evidence on the benefits of our advanced robotic glove design in stroke rehabilitation. We hope our work will significantly advance the field of rehabilitation robotics by improving therapeutic practices, enhancing recovery outcomes, and elevating the quality of life for those facing hand mobility challenges. By integrating new soft robotic hand design with practical application, we aim to create an effective rehabilitation solution for everyone who needs it.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • upper limb
  • stroke rehabilitation
  • soft robotics
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • chronic stage (6 months post-onset);
  • adequate cognition to follow study instructions;
  • being able to sit for 30 minutes;
  • having detectable residual EMG signals from the affected side's flexor digitorum (FD) and extensor digitorum (ED) muscles, as well as the abductor pollicis brevis (APB) and flexor pollicis longus (FPL); and
  • Modified Ashworth Scale (MAS) score indicating levels of finger spasticity of 0, 1, 1+, 2, and 3 (i.e., 0 = no muscle tone to 3 = increase in tone, difficult in passive movement).

Exclusion criteria

Exclusion Criteria:

  • severe dysphasia,
  • conditions that could hinder study compliance, and
  • certain medical or psychological disorders, such as alcoholism and substance abuse
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    new soft robotic glove

    which allows the pressure of the dual-chamber actuators to achieve full DOF for the thumb and fingers

    Device: new soft robotic glove

  • Active comparator
    new soft robotic glove control

    providing only flexion and extension like most robotic systems in the clinical setting

    Device: new soft robotic glove

  • No intervention
    regular rehabilitation control

    Participants will follow their own regular rehabilitation program.

Interventions

  • Devicenew soft robotic glove

    a soft robotic glove, with dual-chamber actuators

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer Assessment for Upper Extremity (FMA-UE)

    It is used to evaluate and measure upper-limb recovery in post-stroke hemiplegic patients, and items are scored on a 3-point ordinal scale

    Time frame: 3-month after intervention

Secondary outcomes

  1. Action Research Arm Test (ARAT)

    The ARAT is a 19-item measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement) to assess upper limb functioning

    Time frame: 3-month after intervention

  2. Modified Ashworth Scale (MAS)

    It measures the spasticity level of wrist, elbow and finger joint.

    Time frame: 3-month after intervention

  3. Box and Block Test (BBT)

    Time frame: 3-month after intervention

  4. Maximum Grip Strength (GRS)

    Time frame: 3-month after intervention

  5. active range of motion (AROM) of fingers

    range of motion is a measurement to identify how far the person's joints range can move in flexion/extension

    Time frame: 3-month after intervention

  6. 5Q-5D-5L questionnaire

    It is a quality of life questionnaire

    Time frame: 3-month after intervention

07

Study locations

1 of 1 sites recruiting
  • Department of Biomedical Engineering, The Chinese University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting
    • Raymond Kai-yu Tong, PhD · Contactkytong@cuhk.edu.hk · +852 3943 8454
    • Raymond Kai-yu Tong, PhD · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2026; primary completion for Dec 2028, 35 months later.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 35 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 29, 2025
First posted
Jan 9, 2026
StartEst.
Jan 2026
Primary completionEst.
Dec 2028
CompletionEst.
Dec 2028
Last update
Jan 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07329075
Responsible party
Raymond KY Tong (Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Jan 9, 2026
Start date
Jan 2026 (estimated)
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Jan 9, 2026

Study contacts

Raymond Tong, PhD
Contact
kytong@cuhk.edu.hk
39438454
Raymond Tong, PhD
principal investigator · Chinese University of Hong Kong

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion